The calls keep coming. Patients are scared. Not just from the imminent threat of the coronavirus, but from its impact on their longer-term enemy – cancer.
Some cancer patients are delaying stem cell transplants and now sit anxiously in a holding pattern. Others are newly diagnosed while their spouse listens in on FaceTime.
A senior executive managing the coronavirus-caused disease COVID-19 while awaiting his CAR T-cell therapy trial prays nothing goes wrong. As he hangs up, his words will never leave me: “Kathy, if I get through this, will there be something else on the other side?”